FDA Import Refusal 1FX-8141752-9/10002/1 — Cipla Pvt Ltd
The FDA refused shipment 1FX-8141752-9/10002/1 from Cipla Pvt Ltd (India) on Aug 19, 2026. The refused product falls under Drugs and Biologics — AZELASTINE, ANTI-HISTAMINE (ANTI-HISTAMINIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 19, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61XDL49 AZELASTINE, ANTI-HISTAMINE (ANTI-HISTAMINIC)
- Charges
- 75